Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 May;62(5):407–413. doi: 10.1136/ard.62.5.407

Diagnostic strategy for the assessment of rheumatoid vasculitis

A Voskuyl 1, J Hazes 1, A Zwinderman 1, E Paleolog 1, F J M van der Meer 1, M Daha 1, F Breedveld 1
PMCID: PMC1754537  PMID: 12695150

Abstract

Objective: To determine the clinical features associated with histologically proven rheumatoid vasculitis (HRV) and the additional diagnostic value of serological markers in an inception cohort of 81 patients with rheumatoid arthritis (RA) suspected of RV.

Methods: The presence and number of recently developed extra-articular manifestations (EAMs) and a weighted EAM score, as well as the levels of serological markers, were compared between 31 patients with RA with histologically proven vasculitis and 50 patients with RA in whom vasculitis could not be documented histologically. The following markers were evaluated: circulating immune complexes, complement components C3 and C4, class-specific rheumatoid factors (IgM RF, IgG RF, IgA RF), antineutrophil cytoplasmic antibodies, antinuclear antibodies, antiendothelial antibodies, circulating intercellular adhesion molecule-1 and -3, circulating vascular cell adhesion molecule and E-selectin, cellular fibronectin, von Willebrand factor antigen, and C reactive protein. The diagnostic value of these markers, in addition to the clinical features, was evaluated with logistic regression analysis.

Results: Peripheral neuropathy or purpura/petechiae, or both, were the most important clinical features to discriminate patients with RA with and without histologically proven RV. The presence of a high number of EAMs and a higher weighted EAM score in patients with RA suspected of vasculitis were also associated with an increased probability of histologically proven RV. After adjustment for EAMs, only the combination of an increased serum IgA RF level and a decreased serum C3 level appeared to make an additional contribution to the diagnosis histologically proven RV. Evidence of systemic vasculitis was found in a muscle biopsy of the rectus femoris in 9/14 (64%) patients with vasculitis with neuropathy and in 3/11 (27%) patients with purpura/petechiae and vasculitis of the skin.

Conclusions: In the diagnostic process of RV the presence of peripheral neuropathy and/or purpura/petechiae or a high weighted EAM score will increase the probability of histologically proven RV. Of the circulating factors previously suggested to be markers for RV only IgA RF and C3 further increase the probability of histologically proven RV and may be useful to guide diagnostic decisions.

Full Text

The Full Text of this article is available as a PDF (147.3 KB).

Figure 1.

Figure 1

Open in a new tab

Relation between the pretest probability of HRV (on the x axis), as calculated with the weighted EAM score, and the post-test probability of HRV (on the y axis) after measuring IgA RF and C3 levels. Increased IgA RF levels were defined as >14 U/ml. Normal IgA RF levels were defined as ⩽14 U/ml. C3 levels were decreased if <0.7 g/l and normal if ⩾0.7 g/l.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Coremans I. E., Hagen E. C., Daha M. R., van der Woude F. J., van der Voort E. A., Kleijburg-van der Keur C., Breedveld F. C. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992 Dec;35(12):1466–1475. doi: 10.1002/art.1780351210. [DOI] [PubMed] [Google Scholar]
  3. Daha M. R., Bertina R. M., Thompson J., Kauffmann R. H., Nicholson-Weller A., Veltkamp J. J., Briët E. Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. Clin Exp Immunol. 1982 Jun;48(3):733–738. [PMC free article] [PubMed] [Google Scholar]
  4. Henriksson K. G. "Semi-open" muscle biopsy technique. A simple outpatient procedure. Acta Neurol Scand. 1979 Jun;59(6):317–323. [PubMed] [Google Scholar]
  5. Heurkens A. H., Gorter A., de Vreede T. M., Edgell C. S., Breedveld F. C., Daha M. R. Methods for the detection of anti-endothelial antibodies by enzyme-linked immunosorbent assay. J Immunol Methods. 1991 Jul 26;141(1):33–39. doi: 10.1016/0022-1759(91)90207-v. [DOI] [PubMed] [Google Scholar]
  6. Heurkens A. H., Hiemstra P. S., Lafeber G. J., Daha M. R., Breedveld F. C. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol. 1989 Oct;78(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  7. Heurkens A. H., Westedt M. L., Breedveld F. C. Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Arch Intern Med. 1991 Nov;151(11):2249–2254. [PubMed] [Google Scholar]
  8. Kauffmann R. H., Van Es L. A., Daha M. R. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. J Immunol Methods. 1979;31(1-2):11–22. doi: 10.1016/0022-1759(79)90281-3. [DOI] [PubMed] [Google Scholar]
  9. Lie J. T. Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. Pathol Annu. 1989;24(Pt 1):25–114. [PubMed] [Google Scholar]
  10. Luqmani R. A., Watts R. A., Scott D. G., Bacon P. A. Treatment of vasculitis in rheumatoid arthritis. Ann Med Interne (Paris) 1994;145(8):566–576. [PubMed] [Google Scholar]
  11. McRorie E. R., Jobanputra P., Ruckley C. V., Nuki G. Leg ulceration in rheumatoid arthritis. Br J Rheumatol. 1994 Nov;33(11):1078–1084. doi: 10.1093/rheumatology/33.11.1078. [DOI] [PubMed] [Google Scholar]
  12. Nusinow S. R., Federici A. B., Zimmerman T. S., Curd J. G. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum. 1984 Dec;27(12):1405–1410. doi: 10.1002/art.1780271211. [DOI] [PubMed] [Google Scholar]
  13. Otten H. G., Daha M. R., de Rooij H. H., Breedveld F. C. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheumatol. 1989 Aug;28(4):310–316. doi: 10.1093/rheumatology/28.4.310. [DOI] [PubMed] [Google Scholar]
  14. Paleolog E. M., Hunt M., Elliott M. J., Feldmann M., Maini R. N., Woody J. N. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum. 1996 Jul;39(7):1082–1091. doi: 10.1002/art.1780390703. [DOI] [PubMed] [Google Scholar]
  15. Puéchal X., Menkès C. J. Prognosis in rheumatoid vasculitis: comment on the article by Voskuyl et al. Arthritis Rheum. 1996 Nov;39(11):1937–1938. doi: 10.1002/art.1780391129. [DOI] [PubMed] [Google Scholar]
  16. Puéchal X., Menkès C. J. Prognosis in rheumatoid vasculitis: comment on the article by Voskuyl et al. Arthritis Rheum. 1996 Nov;39(11):1937–1938. doi: 10.1002/art.1780391129. [DOI] [PubMed] [Google Scholar]
  17. Puéchal X., Menkès C. J. Prognosis in rheumatoid vasculitis: comment on the article by Voskuyl et al. Arthritis Rheum. 1996 Nov;39(11):1937–1938. doi: 10.1002/art.1780391129. [DOI] [PubMed] [Google Scholar]
  18. Puéchal X., Said G., Hilliquin P., Coste J., Job-Deslandre C., Lacroix C., Menkès C. J. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum. 1995 Nov;38(11):1618–1629. doi: 10.1002/art.1780381114. [DOI] [PubMed] [Google Scholar]
  19. Quismorio F. P., Beardmore T., Kaufman R. L., Mongan E. S. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis. Clin Exp Immunol. 1983 May;52(2):333–340. [PMC free article] [PubMed] [Google Scholar]
  20. SOKOLOFF L., WILENS S. L., BUNIM J. J. Arteritis of striated muscle in rheumatoid arthritis. Am J Pathol. 1951 Jan-Feb;27(1):157–173. [PMC free article] [PubMed] [Google Scholar]
  21. Scott D. G., Bacon P. A., Allen C., Elson C. J., Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol. 1981 Jan;43(1):54–63. [PMC free article] [PubMed] [Google Scholar]
  22. Scott D. G., Bacon P. A. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984 Mar;76(3):377–384. doi: 10.1016/0002-9343(84)90654-5. [DOI] [PubMed] [Google Scholar]
  23. Scott D. G., Bacon P. A., Tribe C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981 Jul;60(4):288–297. [PubMed] [Google Scholar]
  24. Tornai I., Declerck P. J., Smets L., Arnout J., Deckmyn H., Caekebeke-Peerlinck K. M., Vermylen J. Measurement of von Willebrand factor antigen in plasma and platelets with an enzyme-linked immunosorbent assay based on two murine monoclonal antibodies. Haemostasis. 1991;21(3):125–134. doi: 10.1159/000216216. [DOI] [PubMed] [Google Scholar]
  25. Tribe C. R., Scott D. G., Bacon P. A. Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol. 1981 Aug;34(8):843–850. doi: 10.1136/jcp.34.8.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vollertsen R. S., Conn D. L., Ballard D. J., Ilstrup D. M., Kazmar R. E., Silverfield J. C. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986 Nov;65(6):365–375. [PubMed] [Google Scholar]
  27. Voskuyl A. E., Emeis J. J., Hazes J. M., van Hogezand R. A., Biemond I., Breedveld F. C. Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitis. Clin Exp Rheumatol. 1998 Jul-Aug;16(4):429–434. [PubMed] [Google Scholar]
  28. Voskuyl A. E., Martin S., Melchers L., Zwinderman A. H., Weichselbraun I., Breedveld F. C. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol. 1995 Apr;34(4):311–315. doi: 10.1093/rheumatology/34.4.311. [DOI] [PubMed] [Google Scholar]
  29. Voskuyl A. E., Zwinderman A. H., Westedt M. L., Vandenbroucke J. P., Breedveld F. C., Hazes J. M. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996 Mar;55(3):190–192. doi: 10.1136/ard.55.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Voskuyl A. E., Zwinderman A. H., Westedt M. L., Vandenbroucke J. P., Breedveld F. C., Hazes J. M. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum. 1996 Feb;39(2):266–271. doi: 10.1002/art.1780390213. [DOI] [PubMed] [Google Scholar]
  31. Voskuyl A. E., van Duinen S. G., Zwinderman A. H., Breedveld F. C., Hazes J. M. The diagnostic value of perivascular infiltrates in muscle biopsy specimens for the assessment of rheumatoid vasculitis. Ann Rheum Dis. 1998 Feb;57(2):114–117. doi: 10.1136/ard.57.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Watts R. A., Carruthers D. M., Scott D. G. Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis. 1995 Nov;54(11):927–929. doi: 10.1136/ard.54.11.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Westedt M. L., Herbrink P., Molenaar J. L., de Vries E., Verlaan P., Stijnen T., Cats A., Lindeman J. Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int. 1985;5(5):209–214. doi: 10.1007/BF00541338. [DOI] [PubMed] [Google Scholar]
  34. Westedt M. L., Meijer C. J., Vermeer B. J., Cats A., de Vries E. Rheumatoid arthritis--the clinical significance of histo- and immunopathological abnormalities in normal skin. J Rheumatol. 1984 Aug;11(4):448–453. [PubMed] [Google Scholar]
  35. Woolf A. D., Wakerley G., Wallington T. B., Scott D. G., Dieppe P. A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis. 1987 Jun;46(6):441–447. doi: 10.1136/ard.46.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES